The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(7-(piperidin-1-yl)quinolin-6-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide ID: ALA4569648
PubChem CID: 66664636
Max Phase: Preclinical
Molecular Formula: C21H20N6O
Molecular Weight: 372.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1cc2cccnc2cc1N1CCCCC1)c1cnn2cccnc12
Standard InChI: InChI=1S/C21H20N6O/c28-21(16-14-24-27-11-5-8-23-20(16)27)25-18-12-15-6-4-7-22-17(15)13-19(18)26-9-2-1-3-10-26/h4-8,11-14H,1-3,9-10H2,(H,25,28)
Standard InChI Key: DNDFTQFYHYKBHO-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
12.1285 -18.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1274 -19.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8354 -20.1105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8336 -18.4732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5422 -18.8784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5430 -19.6974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2515 -20.1045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9598 -19.6937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9551 -18.8716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2460 -18.4682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6603 -18.4587 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6553 -17.6415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3605 -17.2286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9451 -17.2372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2397 -16.2389 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4415 -16.4138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6526 -16.9442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1114 -17.5518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3673 -18.3223 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1641 -18.4863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7045 -17.8737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4457 -17.1056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6691 -20.0995 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6680 -20.9132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3732 -21.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0817 -20.9111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0805 -20.0930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3708 -19.6827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 18 2 0
17 15 1 0
15 16 2 0
16 13 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
8 23 1 0
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.43Molecular Weight (Monoisotopic): 372.1699AlogP: 3.52#Rotatable Bonds: 3Polar Surface Area: 75.42Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.46CX Basic pKa: 6.38CX LogP: 2.86CX LogD: 2.82Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.60Np Likeness Score: -2.03
References 1. Bryan MC, Drobnick J, Gobbi A, Kolesnikov A, Chen Y, Rajapaksa N, Ndubaku C, Feng J, Chang W, Francis R, Yu C, Choo EF, DeMent K, Ran Y, An L, Emson C, Huang Z, Sujatha-Bhaskar S, Brightbill H, DiPasquale A, Maher J, Wai J, McKenzie BS, Lupardus PJ, Zarrin AA, Kiefer JR.. (2019) Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors., 62 (13): [PMID:31082230 ] [10.1021/acs.jmedchem.9b00439 ]